- Clinical Trials
The exercised warrants include all warrants that have been issued to investors in the Company’s public financings to date and represent approximately 70% of the Company’s overall outstanding warrants.
Austin startup a ripe M&A target for big pharma, one expert says
New license agreement expands Genprex’s oncology franchise
Company provides updates on recent regulatory, clinical, operational, and business developments
At Genprex, the health and well-being of the communities we serve, including those with cancer and diabetes, is our top priority.
Proven executive with clinical operations expertise to guide the Company’s clinical programs with gene therapies
Inside the industry’s quest for its next crowning achievement in oncology.
March 30 marks National Doctors’ Day, an annual holiday when we can all acknowledge and show appreciation for our physicians who help save lives everywhere.
These board additions will enhance the Company’s ability to execute on key corporate initiatives.
These seasoned industry professionals combined with the company’s newly strengthened balance sheet will drive key clinical programs.